In his roles, Dr. Carpenter will “unite Speros and Moffitt’s clinical and research expertise with commercial partners to accelerate breakthroughs in cancer prevention and treatment,” according to a March 11 news release from Moffitt.
“With his guidance, we will shape Speros into a global model for groundbreaking discoveries and patient outcomes,” Patrick Hwu, MD, Moffitt president and CEO, said in the release.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
